跳至主要内容
临床试验/PACTR201810909649406
PACTR201810909649406尚未招募未知

Could intraoperative magnesium sulphate protect against postoperative cognitive impairment?

未提供0 个研究点目标入组 80 人开始时间: 2018年10月11日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
80

研究概览

简要总结

intraoperative magnesium sulphate has a protective effect against developing postoperative cognitive dysfunction and reduce the serum level of S100B; the marker of neuronal degeneration

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • 1.Patients who are candidate for elective laparoscopic cholecystectomy
  • 2.Patients should have the ability to read, write and do simple calculations
  • 3.All the participants will be required to offer a written informed con¬sent

排除标准

  • 1.Patient subjected to gross hemodynamic or ventilatory fluctuations during the operation
  • 2.Patient who developed postoperative shock or major bleeding
  • 3.Patient with a history of neurodegenerative disease
  • 4.Patients with concomitant medical or metabolic illness known to affect cognition
  • 5.Patients with evidence of concomitant cerebrovascular stroke
  • 6.Patient with a history of major head trauma
  • 7. Patient with a history of epileptic fits in the last two years
  • 8.Patient with a history of serious hearing or visual impairment
  • 9.Patients with MRI brain showing structural lesion
  • 10.Patients with a history of exposure to drug, toxic substances, alcohol, industrial agents, heavy metals, or any substance known to affect cognition.

研究者

发起方
未提供

相似试验